Trandolapril
(tran-do′la-pril)
Mavik
Classifications: ANGIOTENSINCONVERTING ENZYME (ACE) INHIBITOR; ANTIHYPERTENSIVE
Therapeutic: ANTIHYPERTENSIVE; ACE INHIBITOR
Prototype: Enalapril
Pregnancy Category: D
AVAILABILITY
Tablet
ACTION & THERAPEUTIC EFFECT
Inhibits ACE and interrupts conversion by renin
which leads to the formation of angiotensin II from angiotensin I. Inhibition
of ACE leads to vasodilation as well as to decreased aldosterone. Decreased aldosterone
leads to diuresis and a slight increase in serum potassium. Lowers blood pressure by specific inhibition of ACE. Unlike other ACE
inhibitors, all racial groups respond
to trandolapril, including low-renin
hypertensives.
USES
Treatment of hypertension, reduction of CV
morbidity/ mortality post MI in patients with heart failure.
CONTRAINDICATIONS
Hypersensitivity to trandolapril or ACE inhibitors;
history of angioedema related to previous treatment with an ACE inhibitor;
idiopathic angioedema; pregnancy (category D).
CAUTIOUS USE
Renal impairment, hepatic insufficiency;
patients prone to hypotension (e.g., CHF, ischemic heart disease, aortic stenosis,
CVA, dehydration); SLE, scleroderma; lactation. Safety and effectiveness in
children younger than 18 y are not established.
ROUTE & DOSAGE
Hypertension
Adult: PO 1 mg (2 mg in black patients) once daily, may increase weekly to
2–4 mg once daily (max: 8 mg/day). Lower dose used in patients also taking a diuretic.
Post MI
Adult: PO 1 mg daily for 2 days then increase to 4 mg daily for 2–4 years
Renal Impairment Dosage Adjustment
CrCl less than 30
mL/min: Start with 0.5 mg once daily
Hepatic Impairment Dosage Adjustment
Hepatic cirrhosis: Start with 0.5 mg once daily
ADMINISTRATION
Oral
- Note: If concurrently ordered diuretic cannot be
discontinued 2–3 days before beginning trandolapril therapy, initial dose is
usually reduced to 0.5 mg.
- Dosage adjustments are typically made at
intervals of at least 1 wk.
- Store at 15°–30° C (59°–86° F).
ADVERSE EFFECTS (≥1%)
Body as a Whole: Fatigue, angioedema, fever, malaise. CNS:
Dizziness, drowsiness. CV:
Hypotension, bradycardia, edema, palpitations. GI: Diarrhea.
Respiratory: Cough. Skin: Rash, pruritus. Metabolic:
Hyperkalemia, increased liver enzymes.
Related for Nursing Implications and Drugs Guide Information
- (Parnate) Tranylcypromine Sulfate Uses, Dosage, Side Effects
- Trastuzumab (Herceptin) Uses, Dosage, Side Effects
- Trazodone Hydrochloride Uses, Dosage, Side Effects
- (Remodulin) Treprostinil Sodium Uses, Dosage, Side Effects
- Indomethacin Uses, Dosage, Side Effects
- Ibuprofen Uses, Dosage, Side Effects
INTERACTIONS
Drug: DIURETICS, rituximab
may enhance hypotensive effects. POTASSIUM-SPARING DIURETICS (amiloride,
spironolactone, triamterene), POTASSIUM SUPPLEMENTS, POTASSIUM-CONTAINING SALT SUBSTITUTES, aliskiren, may increase risk of hyperkalemia. May
increase serum levels and toxicity of lithium. NSAIDs may reduce the
therapeutic response. Avoid use with cyclosporine.
PHARMACOKINETICS
Absorption: Rapidly absorbed from GI tract and
converted to active form, trandolaprilat, in liver; 70% of dose reaches systemic circulation as
trandolaprilat. Peak: 4–10 h. Distribution: 80% protein bound; crosses placenta, secreted into breast milk of animals (human secretion
unknown). Metabolism: In liver to trandolaprilat. Elimination: 33% in urine, 66% in feces. Half-Life: 6 h trandolapril, 22.5 h trandolaprilat.
NURSING IMPLICATIONS
Black Box Warning
Trandolapril has been
associated with fetal toxocity.
Assessment & Drug Effects
- Monitor BP carefully for 1–3 h following initial
dose, especially in patients using concurrent diuretics, on salt restriction,
or volume depleted.
- Monitor serum lithium levels frequently with
concurrent lithium therapy and assess for S&S of lithium toxicity; increase
caution when diuretic therapy is also used.
- Monitor lab tests: Baseline LFTs and kidney
function tests; periodic serum potassium and sodium.
Patient & Family Education
- Discontinue drug and immediately report S&S
of angioedema of face or extremities to prescriber. Seek emergency help for
swelling of the tongue or any other sign of potential airway obstruction.
- Be aware that lightheadedness can occur,
especially during early therapy. Excess fluid loss of any kind will increase
risk of hypotension and syncope.
- Report promptly if you are or suspect you are
pregnant.
Artikel keren lainnya:
Belum ada tanggapan untuk "Trandolapril (Mavik) Uses, Dosage, Side Effects"
Post a Comment